Cargando…
microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway
BACKGROUND: We aimed to investigate whether MIR31 is an oncogene in human endometrial cancer and identify the target molecules associated with the malignant phenotype. METHODS: We investigated the growth potentials of MIR31-overexpressing HEC-50B cells in vitro and in vivo. In order to identify the...
Autores principales: | Mitamura, Takashi, Watari, Hidemichi, Wang, Lei, Kanno, Hiromi, Kitagawa, Makiko, Hassan, Mohamed Kamel, Kimura, Taichi, Tanino, Mishie, Nishihara, Hiroshi, Tanaka, Shinya, Sakuragi, Noriaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067122/ https://www.ncbi.nlm.nih.gov/pubmed/24779718 http://dx.doi.org/10.1186/1476-4598-13-97 |
Ejemplares similares
-
Correction: microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway
por: Mitamura, Takashi, et al.
Publicado: (2014) -
P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane
por: Hassan, Mohamed Kamel, et al.
Publicado: (2015) -
Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments
por: Mitamura, Takashi, et al.
Publicado: (2014) -
MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1
por: Dong, Peixin, et al.
Publicado: (2011) -
Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET
por: Mitamura, T, et al.
Publicado: (2013)